George Lin, M.D., Ph.D.

He completed a residency in Anatomic Pathology at Brigham and Women’s Hospital, Harvard Medical School, in Boston, MA, and a fellowship in Dermatopathology in the Harvard Medical School Combined Dermatopathology Fellowship Program with rotations at Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Boston Children’s Hospital, and Massachusetts General Hospital in Boston, MA. Dr. Lin is a member of the Association of Directors of Anatomic and Surgical Pathology, American Society of Dermatopathology, and United States and Canadian Academy of Pathology.

Prior to joining Schweiger Dermatology group, Dr. Lin was the Vice-Chair of Anatomic Pathology, Director of Dermatopathology, and Director of Bone and Soft Tissue Pathology in the Department of Pathology and Laboratory Medicine at Albany Medical Center, Albany, NY, and was previously at Geisinger Medical Center, Danville, PA, for nearly 8 years where he practiced anatomic pathology and dermatopathology and served as the medical director of Geisinger Regional Laboratories – Woodbine.

Before residency training, Dr. Lin was a founder of a vaccine development company, Biological Mimetics, Inc., in Frederick, MD, that was formed with scientists from the National Institutes of Health – National Cancer Institute and served as the Chief Operating Officer and Chief Financial Officer of the company for more than 10 years as well as being a member of the board of directors until 2015. He is an inventor of several patents in the field of virology and has authored more than 25 scientific publications.

Dr. Lin has extensive experience in anatomic pathology with expertise in dermatopathology and bone and soft tissue pathology.